Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment

Journal of Nutrition, Health and Aging

Volumn 12, Issue 1, 2008, Pages

  Barrio, Jorge R ^a   Kepe, V ^a   Satyamurthy, N ^a   Huang, S C ^a   Small, G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid deposition; FDDNP; Mild cognitive impairment; Neuronal losses; Positron emission tomography

Indexed keywords

2,1 [6 [(2 FLUOROETHYL)(METHYL)AMNIO] 2 NAPTHYL]ETHYLIDENE MALONONITRILE FLUORINE 18; 4 FLUORO N[2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL]N(2 PYRIDINYL)BENZAMIDE FLUORINE 18; AMYLOID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; NEUROPROTECTIVE AGENT; RADIOPHARMACEUTICAL AGENT; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOPSY; BEHAVIOR; BRAIN; BRAIN CORTEX; BRAIN MAPPING; BRAIN NERVE CELL; BRAIN REGION; CELL FUNCTION; CELL LOSS; COGNITIVE DEFECT; COMPARATIVE STUDY; CONFERENCE PAPER; CORRELATION ANALYSIS; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE COURSE; EARLY DIAGNOSIS; FOLLOW UP; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HEAD; HEMISPHERE; HIPPOCAMPUS; HUMAN; IMAGING; INJECTION; INTERVENTION STUDY; MOLECULAR IMAGING; MOLECULAR MECHANICS; MONITORING; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK; SENSITIVITY ANALYSIS; TOMOGRAPHY;

EID: 38549142362     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02982589     Document Type: Conference Paper

References (23)

1. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259.
2. Barrio JR, Huang S-C, Cole G, Satyamurthy N, Petric A, Phelps ME, Small G (1999) PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe. J Labelled Compd Radiopharm 42 Suppl 1:S194-S195.
3. Agdeppa ED, Kepe V, Liu J, Small GW, Huang SC, Petric A, Satyamurthy N, Barrio JR (2003) 2-Diaikylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs):-novel diagnostic and therapeutic tools in Alzheimer's disease. Mol Imaging Biol 5:404-417.
4. Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, Read S, Satyamurthy N, Petric A, Huang SC, Barrio JR (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10:24-35.
5. Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR (2006) PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355:2652-2663.
6. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306-319.
7. Verhoeff NP, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, Kung HF, Kung MP, Houle S (2004) In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 12:584-595.
8. Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimer's Dis 3:75-80.
9. Castellani RJ, Lee HG, Perry G, Smith MA (2006) Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. Am J Alzheimers Dis Other Demen 21:126-130.
10. Gomez-Isla T, Price JL, McKeel DW, Jr., Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16:4491-4500.
11. Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron J A, Fletcher A, Cliffe I A, Barf T, Wikstrom H, Sedvall G (1997) Autoradiographic localization of 5-HT1A receptors in the postmortem human brain using [3H]WAY-100635 and [11C]WAY-100635. Brain Res. 745: 96-108
12. Kepe V, Barrio JR, Huang S-C, Ercoli L, Siddarth P, Shoghi-Jadid K, Cole GM, Satyamurthy N, Cummings JL, Small GWW, Phelps M (2006) Serotonin 1A receptors in the living brain of Alzheimer's disease. Proc Natl Acad Sci USA 103:702-707
13. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334:752-758.
14. Liu J, Kepe V, Zabjek A, Petric A, Padgett HC, Satyamurthy N, Barrio JR (2007) High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl) (methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration. Mol Imaging Biol 9:6-16
15. Le Bars D, Lemaire C, Ginovart N, Plenevaux A, Aerts J, Brihaye C, Hassaoun W, Leviel V, Mekhsian P, Weissmann D, Pujol JF, Luxen A, Comar D (1998) High yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoroanalog of WAY-100635. Nucl Med Biol 25: 343-350.
16. Padgett HC, Schmidt DG, Luxen A, Bida GT, Satyamurthy N and Barrio, JR (1989) Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. Int J Rad Appl Instrum [A] 40: 433-445.
17. Kepe V, Huang S-C, Small GW, and Barrio JR (2006) Visualizing Pathology Deposits in the Living Brain of Alzheimer's Disease Patients, Methods Enzymol, 412: 144-160.
18. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41:17-24.
19. Hyman BT, van Hoesen GW, Damasio AR and Barnes CL (1984) Alzheimer's disease: Cell specific pathology isolates the hippocampal formation. Science 225: 1168-1170.
20. Bobinski M, Wegiel J, Tarnawski M, Reisberg B, de Leon MJ, Miller DC, Wisniewski HM (1997) Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 56:414-420.
21. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, Lipton RB (1999) Screening for dementia with the memory impairment screen. Neurology 52:231-238.
22. Minoshima S, Frey KA, Cross DJ, Kuhl DE (2004). Neurochemical imaging of dementias. Sem Nucl Med 34:70-82.
23. Protas H, S-C Huang S-C, Kepe V, Hayashi K, Klunder A, Braskie M, Ercoli L, Bookheimer S, Thompson P, Barrio J, Small G (2007). Hemispheric cortical surface map for assessing the rate of changes of regional cortical FDDNP distribution volume versus MMSE score. J Nucl Med 48 (Supplement 2):419P.